Objectives: Although current guidelines continue to recommend trimodality therapy for stage II to III rectal cancers, a lower incidence of local recurrence has been observed in patients with upper rectal tumors, including those in the rectosigmoid. In practice, patients with upper rectal tumors may not be receiving all 3 modalities of therapy. Patterns of care for patients with rectosigmoid cancers have not previously been described. Methods: The National Cancer Database (NCDB) was...
Mark above section as read
Publication date: June 2020Source: World Neurosurgery, Volume 138Author(s): Yingda Li, Barth Green
Publication date: June 2020Source: World Neurosurgery, Volume 138Author(s): Fan Chen, Yuehai Pan, Yongliang Teng, Xingchen Pan, Ying Yu
Publication date: June 2020Source: World Neurosurgery, Volume 138Author(s): Katsunori Shijo, Sodai Yoshimura, Fumi Mori, Shun Yamamuro, Koichiro Sumi, Hideki Oshima, Atsuo Yoshino
Publication date: June 2020Source: World Neurosurgery, Volume 138Author(s): Ai Peng Tan
Mark above section as read
Publication date: Available online 31 March 2020Source: Journal of Neuroscience MethodsAuthor(s): Alexander J. Ehrenberg, Dulce Ovando Morales, Antonia M.H. Piergies, Song Hua Li, Jorge Santos Tejedor, Mihovil Mladinov, Jan Mulder, Lea T. Grinberg
Mark above section as read
Abstract Background and aims The prevalence of the non-alcoholic fatty liver disease (NAFLD) in developed countries is up to 30% of the general population, and 50% of patients present type 2 diabetes mellitus (DM2). Fibrosis is the most important prognostic factor in NAFLD. The aim of this study was to search evidence for an early diagnosis of liver fibrosis in subjects with DM2 and to evaluate potential risk and protective factors....
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου